ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,156Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 19

$438K Total Retail Price of All Prescriptions

Rank: 9 out of 19

282 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 282 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,488 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 39.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 470 428 1 4
SIMVASTATIN 410 340 2 7
LISINOPRIL 342 298 3 6
LOSARTAN POTASSIUM 338 289 4 43
POTASSIUM CHLORIDE 332 303 5 11
FUROSEMIDE 312 288 6 2
OMEPRAZOLE 305 274 7 5
GABAPENTIN 298 245 8 12
AMLODIPINE BESYLATE 293 257 9 3
SERTRALINE HCL 246 186 10 25
WARFARIN SODIUM 242 233 11 10
METOPROLOL TARTRATE 231 222 12 13
RANITIDINE HCL 214 159 13 17
GLIMEPIRIDE 208 166 14 62
HYDROCODONE-ACETAMINOPHEN 196 158 S3 15 1
TAMSULOSIN HCL 181 144 16 35
HYDROCHLOROTHIAZIDE 170 136 17 28
METFORMIN HCL 170 149 17 26
NEXIUM 161 144 19 37
ATENOLOL 161 158 19 36
TRAMADOL HCL 161 145 19 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 157 132 22 54
PRAVASTATIN SODIUM 148 112 23 32
METOPROLOL SUCCINATE 147 127 24 33
ALLOPURINOL 131 119 25 64
CARVEDILOL 125 122 26 23
PAROXETINE HCL 118 118 27 88
LANTUS 100 92 28 29
FLUTICASONE PROPIONATE 100 67 28 45
DOXYCYCLINE HYCLATE 93 66 30 134
TRAZODONE HCL 90 76 31 20
PLAVIX 90 75 31 39
DIGOXIN 88 88 33 40
RISPERIDONE 83 48 34 18
AMLODIPINE BESYLATE-BENAZEPRIL 78 78 35 129
FINASTERIDE 78 74 35 97
NIFEDIPINE ER 75 75 37 126
KLOR-CON 10 72 51 38 223
LOSARTAN-HYDROCHLOROTHIAZIDE 71 57 39 190
CLONIDINE HCL 70 70 40 56
PHENYTOIN SODIUM EXTENDED 69 25 41 85
CLOPIDOGREL 68 51 42 30
DIOVAN 67 46 43 41
MAPROTILINE HCL 66 66 10 44 225
ZOLPIDEM TARTRATE 65 63 45 34
DIOVAN HCT 59 59 46 99
NORTRIPTYLINE HCL 58 44 47 166
FLUCONAZOLE 57 57 48 136
DICLOFENAC SODIUM 56 56 49 241
INSULIN SYRINGE 55 50 50 152
ALENDRONATE SODIUM 54 54 51 50
KLOR-CON M10 54 46 51 73
PREDNISONE 53 41 53 63
MECLIZINE HCL 52 52 54 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.